Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2007

Aug 16, 2007

34519_dirs_2007-08-16_d602ec1a-5fdf-43ff-9986-e42349096a78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2007-08-14

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-08-14 Common Stock, par value $0.10 per share P 1000 $3.82 Acquired 399740 Direct
2007-08-14 Common Stock, par value $0.10 per share P 1000 $3.814 Acquired 400740 Direct
2007-08-14 Common Stock, par value $0.10 per share P 200 $3.82 Acquired 400940 Direct
2007-08-15 Common Stock, par value $0.10 per share P 800 $3.94 Acquired 401740 Direct
2007-08-15 Common Stock, par value $0.10 per share P 800 $3.84 Acquired 402540 Direct
2007-08-15 Common Stock, par value $0.10 per share P 183 $3.80 Acquired 402723 Direct
2007-08-15 Common Stock, par value $0.10 per share P 1000 $3.78 Acquired 403723 Direct
2007-08-16 Common Stock, par value $0.10 per share P 200 $3.72 Acquired 403923 Direct
2007-08-16 Common Stock, par value $0.10 per share P 300 $3.73 Acquired 404223 Direct

Footnotes

F1: These shares of common stock were acquired by Arterio, Inc. a corporation owned solely by Mr. Rothschild.

F2: This figure includes 200,710 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.